IL6 and neoplasm: Such substances trigger the production of ROS, the recruitment and activation of immune cells to release inflammatory factors, such as tumor necrosis factor (TNF-α) and interleukin-6 (IL-6), thus promoting tumor metastasis [[28], [29], [30]].